the isolation and fractionation of human anti- dextran antibodies (Schlossman & Kabat, 1962). The affinity of the desired protein towards the dextran gel is exploited in both cases. Subsequent displacement by low-molecular-weight competitive inhibitors (haptens) yields a purified protein.
No takes yet. Share an insight, caveat, or question.
Czerkawski et al. (1965) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: